Understanding Spindle Cell Lesions of the Breast: Diagnostic Pitfalls, Immunohistochemical Strategies, and Surgical-Oncological Implications.
Authors: Prof. Dr. Md. Golam Mostafa
Institution: Anowara Medical Services
Introduction
Background: Spindle cell neoplasms of the breast account for less than 5% of all breast lesions, yet they represent one of the most complex challenges in diagnostic breast pathology. The spectrum ranges from benign reactive proliferations to low-grade locally aggressive lesions and highly malignant carcinomas or sarcomas. Because these entities exhibit overlapping morphologic features, accurate differentiation on limited core needle biopsy (CNB) specimens is crucial to prevent inappropriate surgical or oncological management.
Methods
Objective: To provide breast surgeons, surgical oncologists, and general surgeons with a practical, evidence-based diagnostic framework for evaluating spindle cell lesions of the breast, emphasizing critical immunohistochemical (IHC) strategies, surgical margin requirements, and therapeutic pitfalls. Diagnostic Approach & Key Findings: Breast spindle cell lesions are broadly categorized into biphasic and monophasic (pure spindle cell) proliferations. A major diagnostic challenge involves distinguishing low-grade, bland spindle cell lesions—such as fibromatosis (desmoid tumor), pseudoangiomatous stromal hyperplasia (PASH), and myofibroblastoma—from fibromatosis-like metaplastic carcinoma (FL-MBC). Fibromatosis requires differentiation via nuclear $\beta$-catenin reactivity and negative cytokeratins, whereas FL-MBC displays reactivity for broad-spectrum and high-molecular-weight cytokeratins (CK5/6, CK14) and p63. Among high-grade entities, spindle cell metaplastic breast carcinoma (SCLC) is far more common than primary breast sarcomas or malignant phyllodes tumors. High-grade SCLC can undergo extensive Epithelial-Mesenchymal Transition (EMT), leading to complete loss of cytokeratin and p63 expression on CNB, posing a significant diagnostic trap. Broad IHC panels combining epithelial (AE1/AE3, CK7, p63, p40) and mesenchymal/myofibroblastic markers (CD34, SMA, desmin, beta-catenin) are mandatory for definitive subtyping.
Results
Clinical & Surgical Implications: Treatment strategies depend heavily on accurate histological subtyping. Fibromatosis and low-grade FL-MBC necessitate wide local excision with clear negative margins due to high local recurrence rates, though nodal metastasizing potential is negligible. High-grade SCLC demonstrates aggressive biologic behavior with high rates of distant hematogenous metastasis and poor responsiveness to conventional anthracycline/taxane-based chemotherapy regimens. Routine axillary lymph node dissection is generally not indicated for pure spindle cell metaplastic carcinomas given their significantly lower incidence of nodal metastasis (30%) compared to conventional invasive ductal carcinoma.
Conclusion
Conclusion: Any ambiguous spindle cell lesion on core needle biopsy lacking a definitive benign diagnosis should be treated as a lesion of uncertain malignant potential warranting excision and multidisciplinary tumor board review. Pathologic-surgical-oncological collaboration is essential to ensure appropriate surgical margin planning and tailored systemic management.